Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 284

2.

TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.

Kanazawa K, Kudo A.

J Bone Miner Res. 2005 May;20(5):840-7. Epub 2004 Dec 20.

3.

Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice.

Li P, Schwarz EM, O'Keefe RJ, Ma L, Looney RJ, Ritchlin CT, Boyce BF, Xing L.

Arthritis Rheum. 2004 Jan;50(1):265-76.

4.
5.

Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.

Hayashi S, Yamada T, Tsuneto M, Yamane T, Takahashi M, Shultz LD, Yamazaki H.

J Immunol. 2003 Nov 15;171(10):5130-9.

7.

Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis.

Park H, Jung YK, Park OJ, Lee YJ, Choi JY, Choi Y.

J Immunol. 2005 Dec 1;175(11):7193-201.

8.

Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.

Yang S, Takahashi N, Yamashita T, Sato N, Takahashi M, Mogi M, Uematsu T, Kobayashi Y, Nakamichi Y, Takeda K, Akira S, Takada H, Udagawa N, Furusawa K.

J Immunol. 2005 Aug 1;175(3):1956-64.

9.

LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.

Edwards JR, Sun SG, Locklin R, Shipman CM, Adamopoulos IE, Athanasou NA, Sabokbar A.

Arthritis Rheum. 2006 May;54(5):1451-62.

10.
11.

TNF receptor type 1 regulates RANK ligand expression by stromal cells and modulates osteoclastogenesis.

Abu-Amer Y, Abbas S, Hirayama T.

J Cell Biochem. 2004 Nov 15;93(5):980-9.

PMID:
15389885
12.

Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.

Lubberts E, Oppers-Walgreen B, Pettit AR, Van Den Bersselaar L, Joosten LA, Goldring SR, Gravallese EM, Van Den Berg WB.

Arthritis Rheum. 2002 Nov;46(11):3055-64.

13.

TRAF5 functions in both RANKL- and TNFalpha-induced osteoclastogenesis.

Kanazawa K, Azuma Y, Nakano H, Kudo A.

J Bone Miner Res. 2003 Mar;18(3):443-50.

14.

Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.

Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT.

J Bone Miner Res. 2001 Oct;16(10):1787-94.

15.

Osteoclast precursors, RANKL/RANK, and immunology.

Xing L, Schwarz EM, Boyce BF.

Immunol Rev. 2005 Dec;208:19-29. Review.

PMID:
16313338
16.

A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss.

Aoki K, Saito H, Itzstein C, Ishiguro M, Shibata T, Blanque R, Mian AH, Takahashi M, Suzuki Y, Yoshimatsu M, Yamaguchi A, Deprez P, Mollat P, Murali R, Ohya K, Horne WC, Baron R.

J Clin Invest. 2006 Jun;116(6):1525-34. Epub 2006 May 4.

17.

RANKL-stimulated TNFalpha production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signaling pathways.

Nakao A, Fukushima H, Kajiya H, Ozeki S, Okabe K.

Biochem Biophys Res Commun. 2007 Jun 15;357(4):945-50. Epub 2007 Apr 19.

PMID:
17467668
18.

RANKL is an essential cytokine mediator of polymethylmethacrylate particle-induced osteoclastogenesis.

Clohisy JC, Frazier E, Hirayama T, Abu-Amer Y.

J Orthop Res. 2003 Mar;21(2):202-12.

19.

Synovial fibroblasts promote osteoclast formation by RANKL in a novel model of spontaneous erosive arthritis.

Wu Y, Liu J, Feng X, Yang P, Xu X, Hsu HC, Mountz JD.

Arthritis Rheum. 2005 Oct;52(10):3257-68.

20.

Supplemental Content

Support Center